|
|
| | 4'-Hydroxyphenyl Carvedilol Basic information |
| | 4'-Hydroxyphenyl Carvedilol Chemical Properties |
| Melting point | 163-165°C | | Boiling point | 702.0±60.0 °C(Predicted) | | density | 1.305±0.06 g/cm3(Predicted) | | storage temp. | -20°C Freezer | | solubility | Acetonitrile (Slightly), DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 9.94±0.20(Predicted) | | color | White to Light Brown | | InChI | 1S/C24H26N2O5/c1-29-23-13-16(27)9-10-21(23)30-12-11-25-14-17(28)15-31-22-8-4-7-20-24(22)18-5-2-3-6-19(18)26-20/h2-10,13,17,25-28H,11-12,14-15H2,1H3 | | InChIKey | ZCJHEORDHXCJNB-UHFFFAOYSA-N | | SMILES | [nH]1c2c(c4c1cccc4)c(ccc2)OCC(O)CNCCOc3c(cc(cc3)O)OC |
| WGK Germany | WGK 3 | | HS Code | 9999999999 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Aquatic Chronic 2 STOT RE 2 |
| | 4'-Hydroxyphenyl Carvedilol Usage And Synthesis |
| Description | 4’-hydroxyphenyl Carvedilol is a metabolite of carvedilol that is a more potent β-adrenergic receptor antagonist than carvedilol but has weaker vasodilatory activity. It is formed through oxidation primarily by the cytochrome P450 (CYP) isoform CYP2D6. 4’-hydroxyphenyl Carvedilol inhibits the formation of DPPH radicals in a cell-free assay. | | Chemical Properties | Off-White Solid | | Uses | A metabolite of Carvedilol (C184625). It is used in the treatment of hypertension. | | Uses | 4'-Hydroxyphenyl Carvedilol is an optically active metabolite of Carvedilol which is a multiple-action, neurohormonal antagonist that is used in the treatment of hypertension. | | Uses | An optically active metabolite of Carvedilol (C184625), a nonselective -adrenergic blocker with α1-blocking activity. | | Definition | ChEBI: 4'-Hydroxyphenyl Carvedilol is a member of carbazoles. | | References | [1] DAXESH P. PATEL. UPLC-MS/MS assay for the simultaneous quantification of carvedilol and its active metabolite 4′-hydroxyphenyl carvedilol in human plasma to support a bioequivalence study in healthy volunteers[J]. Biomedical Chromatography, 2013, 27 8: 974-986. DOI: 10.1002/bmc.2889 [2] H G OLDHAM S E C. In vitro identification of the human cytochrome P450 enzymes involved in the metabolism of R(+)- and S(-)-carvedilol.[J]. Drug Metabolism and Disposition, 1997, 25 8: 970-977.
[3] THOMAS C MALIG. Comparison of free-radical inhibiting antioxidant properties of carvedilol and its phenolic metabolites.[J]. MedChemComm, 2017: 606-615. DOI: 10.1039/c7md00014f |
| | 4'-Hydroxyphenyl Carvedilol Preparation Products And Raw materials |
|